Go here to learn more or to get a mailed copy.
Home » YI Awards » YI Award Recipients 2013
Shalini S. Yadav, PhD:
Mount Sinai School of Medicine
Mentors:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer
Shalini S. Yadav, PhD:
Mount Sinai School of Medicine
Mentors:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer
Daniel Thorek, PhD:
Johns Hopkins University
Mentors:
David Scheinberg, MD, PhD and Steve Larson, MD
Project Title:
Alpha-particle therapy by 225Actinium-labeled prostate kallikrein-specific antibody to eradicate advanced disease
Daniel Thorek, PhD:
Johns Hopkins University
Mentors:
David Scheinberg, MD, PhD and Steve Larson, MD
Project Title:
Alpha-particle therapy by 225Actinium-labeled prostate kallikrein-specific antibody to eradicate advanced disease
Nicole Simone, MD:
Thomas Jefferson University
Mentors:
Adam Dicker, MD, PhD, Karen Knudsen, PhD and Peter Carroll, MD
Project Title:
Metabolic approaches for targeting multiple components of the IGF-1R pathway in prostate cancer
Nicole Simone, MD:
Thomas Jefferson University
Mentors:
Adam Dicker, MD, PhD, Karen Knudsen, PhD and Peter Carroll, MD
Project Title:
Metabolic approaches for targeting multiple components of the IGF-1R pathway in prostate cancer
Matthew Schiewer, PhD:
Thomas Jefferson University
Mentor:
Karen Knudsen, PhD
Project Title:
Determining the translation capacity of the PARP-1/AR axis in prostate cancer
Matthew Schiewer, PhD:
Thomas Jefferson University
Mentor:
Karen Knudsen, PhD
Project Title:
Determining the translation capacity of the PARP-1/AR axis in prostate cancer
Jennifer Rider, ScD:
Harvard School of Public Health
Mentors:
Lorelei Mucci, ScD and Myles Brown, MD
Project Title:
The immunomodulatory and androgen-associated actions of vitamin D in prostate cancer
Jennifer Rider, ScD:
Harvard School of Public Health
Mentors:
Lorelei Mucci, ScD and Myles Brown, MD
Project Title:
The immunomodulatory and androgen-associated actions of vitamin D in prostate cancer
Colin Pritchard, MD, PhD:
University of Washington
Mentors:
Peter Nelson, MD
Project Title:
Targeting the ‘Hypermutated Subtype’ of Prostate Cancer: From Mechanism to Implementation of Genomic Testing for Precision Therapy”
Colin Pritchard, MD, PhD:
University of Washington
Mentors:
Peter Nelson, MD
Project Title:
Targeting the ‘Hypermutated Subtype’ of Prostate Cancer: From Mechanism to Implementation of Genomic Testing for Precision Therapy”
Antonina Mitrofanova, PhD:
Rutgers, The State University of New Jersey
Mentor:
Michael Shen, PhD
Project Title:
A systems biology approach to identify and evaluate novel drug targets for aggressive prostate cancer
Antonina Mitrofanova, PhD:
Rutgers, The State University of New Jersey
Mentor:
Michael Shen, PhD
Project Title:
A systems biology approach to identify and evaluate novel drug targets for aggressive prostate cancer
Rohit Mehra, MD:
University of Michigan School of Medicine
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
Clinicopathological characterization of novel lncRNAs in prostate cancer risk stratification
Rohit Mehra, MD:
University of Michigan School of Medicine
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
Clinicopathological characterization of novel lncRNAs in prostate cancer risk stratification
Theodoros Karantanos, MD:
MD Anderson Cancer Center
Mentors:
Timothy Thompson, PhD and Christopher Logothetis, MD
Project Title:
The role of aerobic glycolysis in the development of castrate resistant prostate cancer
Theodoros Karantanos, MD:
MD Anderson Cancer Center
Mentors:
Timothy Thompson, PhD and Christopher Logothetis, MD
Project Title:
The role of aerobic glycolysis in the development of castrate resistant prostate cancer
Vivek Arora, MD, PhD:
Washington University
Mentor:
Charles Sawyers, MD
Project Title:
Defining strategies to overcome enzalutamide (Xtandi) resistance
Vivek Arora, MD, PhD:
Washington University
Mentor:
Charles Sawyers, MD
Project Title:
Defining strategies to overcome enzalutamide (Xtandi) resistance
Jennifer Bishop, PhD:
University of British Columbia
Mentors:
Martin Gleave, MD and Amina Zoubeidi, PhD
Project Title:
Regulation of cell plasticity by the androgen receptor: A novel mechanism of enzalutamide (Xtandi) resistance
Jennifer Bishop, PhD:
University of British Columbia
Mentors:
Martin Gleave, MD and Amina Zoubeidi, PhD
Project Title:
Regulation of cell plasticity by the androgen receptor: A novel mechanism of enzalutamide (Xtandi) resistance
Irfan Asangani, PhD:
University of Michigan
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
Characterization and therapeutic targeting of MMSET in prostate cancer
Irfan Asangani, PhD:
University of Michigan
Mentor:
Arul Chinnaiyan, MD, PhD
Project Title:
Characterization and therapeutic targeting of MMSET in prostate cancer
Charles Chan, PhD:
Stanford University School of Medicine
Mentors:
Irving Weissman, MD and Michael Longaker, MD
Project Title:
Identification and therapeutic targeting of cancer stem cell niche interactions in metastatic prostate bone marrow disease
Charles Chan, PhD:
Stanford University School of Medicine
Mentors:
Irving Weissman, MD and Michael Longaker, MD
Project Title:
Identification and therapeutic targeting of cancer stem cell niche interactions in metastatic prostate bone marrow disease
Chia-Yi Chu, PhD:
Cedars-Sinai Medical Center
Mentor:
Leland Chung, PhD
Project Title:
Metastasis-initiating cells (MICs) as predictors of lethal progression of human prostate cancer
Chia-Yi Chu, PhD:
Cedars-Sinai Medical Center
Mentor:
Leland Chung, PhD
Project Title:
Metastasis-initiating cells (MICs) as predictors of lethal progression of human prostate cancer
Michael Evans, PhD:
University of California, San Francisco
Mentors:
Charles Sawyers, MD and Jason Lewis, PhD
Project Title:
Exploiting the genetics of advanced prostate cancer for tumor detection and therapy with transferrin-based radionuclides
Michael Evans, PhD:
University of California, San Francisco
Mentors:
Charles Sawyers, MD and Jason Lewis, PhD
Project Title:
Exploiting the genetics of advanced prostate cancer for tumor detection and therapy with transferrin-based radionuclides
Jason A. Efstathiou, MD, DPhil:
Massachusetts General Hospital
Mentor:
Matthew R. Smith, MD, PhD
Project Title:
Predictors of Response and Failure to Radiotherapy for Prostate Cancer in a Randomized Trial
Jason A. Efstathiou, MD, DPhil:
Massachusetts General Hospital
Mentor:
Matthew R. Smith, MD, PhD
Project Title:
Predictors of Response and Failure to Radiotherapy for Prostate Cancer in a Randomized Trial
Geraldine Gueron, PhD:
Iquibicen-Conicet (Argentina)
Mentor:
Elba Vazquez, PhD
Project Title:
Proteome-base biomarkers in prostate cancer: protein profiling using mass spectrometry, bioinformatics based approach and tissue microarray technology
Geraldine Gueron, PhD:
Iquibicen-Conicet (Argentina)
Mentor:
Elba Vazquez, PhD
Project Title:
Proteome-base biomarkers in prostate cancer: protein profiling using mass spectrometry, bioinformatics based approach and tissue microarray technology
Mentors:
Philip Kantoff, MD and Christopher Sweeney, MBBS
Project Title:
Clinical exploration of innovative targeted and immune modulating therapies in prostate cancer
Mentors:
Philip Kantoff, MD and Christopher Sweeney, MBBS
Project Title:
Clinical exploration of innovative targeted and immune modulating therapies in prostate cancer
Emmanuel Antonarakis, MD:
Johns Hopkins University School of Medicine
Mentors:
Michael Carducci, MD and Jun Luo, PhD
Project Title:
Understanding mechanisms of response and resistance to abiraterone (Zytiga) and enzalutamide (Xtandi) in men with metastatic castration-resistant prostate cancer, by interrogation of tumor biopsies for androgen receptor splice variants.
Emmanuel Antonarakis, MD:
Johns Hopkins University School of Medicine
Mentors:
Michael Carducci, MD and Jun Luo, PhD
Project Title:
Understanding mechanisms of response and resistance to abiraterone (Zytiga) and enzalutamide (Xtandi) in men with metastatic castration-resistant prostate cancer, by interrogation of tumor biopsies for androgen receptor splice variants.
Syed Adnan Ali, MD:
Mount Sinai School of Medicine
Mentor:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer
Syed Adnan Ali, MD:
Mount Sinai School of Medicine
Mentor:
Ashutosh Tewari, MD
Project Title:
Intratumor Heterogeneity (ITH) in Prostate Cancer